Literature DB >> 7698087

Effect of acetaminophen on glutathione levels in rat testis and lung.

L Micheli1, D Cerretani, A I Fiaschi, G Giorgi, M R Romeo, F M Runci.   

Abstract

Glutathione (GSH) levels in rat testis and lung after oral administration (3 g/kg) of acetaminophen (APAP) were studied. At the administered dose APAP is present in each organ and influences the GSH levels. APAP value of 114 micrograms/g was obtained in testis at 6 hr (peak time); in the lung the Cmax was 92 mu/g at 8 hr and this value lasted several hours longer than that in testis. GSH levels are also affected differently in the organs studied after APAP administration; the lungs seem to be the primary organ undergoing the depleting action of APAP. This process could not only cause toxicity, but also predispose those organs to the action of toxic compounds responsible for specific pathologies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698087      PMCID: PMC1566779          DOI: 10.1289/ehp.94102s963

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  12 in total

1.  Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin.

Authors:  J A Hinson; S D Nelson; J R Mitchell
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Protective effects of selenium on acetaminophen-induced hepatotoxicity in the rat.

Authors:  R C Schnell; K S Park; M H Davies; B A Merrick; S W Weir
Journal:  Toxicol Appl Pharmacol       Date:  1988-08       Impact factor: 4.219

4.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione.

Authors:  J R Mitchell; D J Jollow; W Z Potter; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

5.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

6.  Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins.

Authors:  J B Bartolone; R B Birge; K Sparks; S D Cohen; E A Khairallah
Journal:  Biochem Pharmacol       Date:  1988-12-15       Impact factor: 5.858

7.  Micro high-performance liquid chromatographic assay of acetaminophen and its major metabolites in plasma and urine.

Authors:  D Jung; N U Zafar
Journal:  J Chromatogr       Date:  1985-04-12

8.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen.

Authors:  D J Jollow; S S Thorgeirsson; W Z Potter; M Hashimoto; J R Mitchell
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

Review 9.  [Paracetamol. Present status of knowledge in 1989].

Authors:  P Lechat; R Kisch
Journal:  Therapie       Date:  1989 Sep-Oct       Impact factor: 2.070

10.  Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D-cysteine in mice.

Authors:  G B Corcoran; B K Wong
Journal:  J Pharmacol Exp Ther       Date:  1986-07       Impact factor: 4.030

View more
  16 in total

1.  Paracetamol use in pregnancy and wheezing in early childhood.

Authors:  S O Shaheen; R B Newson; A Sherriff; A J Henderson; J E Heron; P G J Burney; J Golding
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

2.  Effect of prenatal exposure to fine particulate matter and intake of Paracetamol (Acetaminophen) in pregnancy on eczema occurrence in early childhood.

Authors:  Wieslaw Jedrychowski; John D Spengler; Umberto Maugeri; Rachel L Miller; Dorota Budzyn-Mrozek; Matt Perzanowski; Elzbieta Flak; Elzbieta Mroz; Renata Majewska; Irena Kaim; Frederica Perera
Journal:  Sci Total Environ       Date:  2011-10-01       Impact factor: 7.963

3.  Frequent paracetamol use and asthma in adults.

Authors:  S O Shaheen; J A Sterne; C E Songhurst; P G Burney
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

4.  The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: a longitudinal birth-cohort study.

Authors:  Alemayehu Amberbir; Girmay Medhin; Atalay Alem; John Britton; Gail Davey; Andrea Venn
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

Review 5.  Acetaminophen use: a risk for asthma?

Authors:  Henning Allmers; Christoph Skudlik; Swen Malte John
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

6.  Circulating autoantibodies in patients with aspirin-intolerant asthma: an epiphenomenon related to airway inflammation.

Authors:  Young-Min Ye; Dong-Ho Nahm; Sang-Ha Kim; Seung-Hyun Kim; Jeong-Hee Choi; Chang-Hee Suh; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

7.  Paracetamol use in early life and asthma: prospective birth cohort study.

Authors:  Adrian J Lowe; John B Carlin; Catherine M Bennett; Clifford S Hosking; Katrina J Allen; Colin F Robertson; Christine Axelrad; Michael J Abramson; David J Hill; Shyamali C Dharmage
Journal:  BMJ       Date:  2010-09-15

Review 8.  Strategies for primary prevention of atopy in children.

Authors:  Christina E Ciaccio; Jay M Portnoy
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

9.  Effects of early life paracetamol use on the incidence of allergic disease and sensitization: 5 year follow-up of an Ethiopian birth cohort.

Authors:  Alemayehu Amberbir; Girmay Medhin; Charlotte Hanlon; John Britton; Gail Davey; Andrea Venn
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

10.  Prenatal Paracetamol Exposure and Wheezing in Childhood: Causation or Confounding?

Authors:  Enrica Migliore; Daniela Zugna; Claudia Galassi; Franco Merletti; Luigi Gagliardi; Laura Rasero; Morena Trevisan; Franca Rusconi; Lorenzo Richiardi
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.